dbo:abstract
|
- Die Leichtketten-Speicherkrankheit ist eine seltene Speicherkrankheit mit Ablagerungen monoklonaler Leichtketten (Immunoglobuline) in verschiedenen Organen, insbesondere der Niere und wird von der WHO zu den “monoclonal deposition diseases” gezählt. Im Gegensatz zur AL-Amyloidose erfolgt die Ablagerung nicht in Amyloidfibrillen. Synonyme sind: Leichtketten-Ablagerungs-Krankheit; Leichtkettenerkrankung; englisch light-chain deposition disease; LCDD Die Erstbeschreibung stammt aus dem Jahre 1976 durch die US-amerikanischen Ärzte Russell E. Randall und Mitarbeiter. (de)
- Light chain deposition disease (LCDD) is a rare blood cell disease which is characterized by deposition of fragments of infection-fighting immunoglobulins, called light chains (LCs), in the body. LCs are normally cleared by the kidneys, but in LCDD, these light chain deposits damage organs and cause disease. The kidneys are almost always affected and this often leads to kidney failure. About half of people with light chain deposition disease also have a plasma cell dyscrasia, a spectrum of diseases that includes multiple myeloma, Waldenström's macroglobulinemia, and the monoclonal gammopathy of undetermined significance premalignant stages of these two diseases. Unlike in AL amyloidosis, in which light chains are laid down in characteristic amyloid deposits, in LCDD, light chains are deposited in non-amyloid granules. (en)
|
dbo:eMedicineSubject
| |
dbo:icd10
| |
dbo:icd9
| |
dbo:orpha
| |
dbo:wikiPageExternalLink
| |
dbo:wikiPageID
| |
dbo:wikiPageLength
|
- 5967 (xsd:nonNegativeInteger)
|
dbo:wikiPageRevisionID
| |
dbo:wikiPageWikiLink
| |
dbp:emedicinesubj
| |
dbp:icd
|
- 203.800000 (xsd:double)
- (en)
- D89.8 (en)
|
dbp:name
|
- Light chain deposition disease (en)
|
dbp:orphanet
| |
dbp:synonyms
| |
dbp:wikiPageUsesTemplate
| |
dcterms:subject
| |
gold:hypernym
| |
rdf:type
| |
rdfs:comment
|
- Die Leichtketten-Speicherkrankheit ist eine seltene Speicherkrankheit mit Ablagerungen monoklonaler Leichtketten (Immunoglobuline) in verschiedenen Organen, insbesondere der Niere und wird von der WHO zu den “monoclonal deposition diseases” gezählt. Im Gegensatz zur AL-Amyloidose erfolgt die Ablagerung nicht in Amyloidfibrillen. Synonyme sind: Leichtketten-Ablagerungs-Krankheit; Leichtkettenerkrankung; englisch light-chain deposition disease; LCDD Die Erstbeschreibung stammt aus dem Jahre 1976 durch die US-amerikanischen Ärzte Russell E. Randall und Mitarbeiter. (de)
- Light chain deposition disease (LCDD) is a rare blood cell disease which is characterized by deposition of fragments of infection-fighting immunoglobulins, called light chains (LCs), in the body. LCs are normally cleared by the kidneys, but in LCDD, these light chain deposits damage organs and cause disease. The kidneys are almost always affected and this often leads to kidney failure. About half of people with light chain deposition disease also have a plasma cell dyscrasia, a spectrum of diseases that includes multiple myeloma, Waldenström's macroglobulinemia, and the monoclonal gammopathy of undetermined significance premalignant stages of these two diseases. Unlike in AL amyloidosis, in which light chains are laid down in characteristic amyloid deposits, in LCDD, light chains are depos (en)
|
rdfs:label
|
- Leichtketten-Speicherkrankheit (de)
- Light chain deposition disease (en)
|
owl:sameAs
| |
prov:wasDerivedFrom
| |
foaf:isPrimaryTopicOf
| |
foaf:name
|
- Light chain deposition disease (en)
|
is dbo:wikiPageDisambiguates
of | |
is dbo:wikiPageRedirects
of | |
is dbo:wikiPageWikiLink
of | |
is foaf:primaryTopic
of | |